Exploring the association between air pollutants and non-small cell lung cancer using network toxicology and machine learning

利用网络毒理学和机器学习探索空气污染物与非小细胞肺癌之间的关联

阅读:1

Abstract

BACKGROUND: Non-small cell lung cancer (NSCLC) is a leading cause of cancer-related mortality worldwide. The urgent need to understand its risk factors and develop effective treatment strategies drives ongoing research in this field. Among various environmental factors, air pollutants have emerged as potential risk factors. Therefore, in-depth exploration is necessary to elucidate their impact on NSCLC pathogenesis. METHODS: This study employs a multifaceted approach combining transcriptomic data analysis, machine learning, and molecular docking simulations to assess the association between air pollutants-carbon monoxide (CO), nitric oxide (NO), nitrogen dioxide (NO₂), sulfur dioxide (SO₂), benzo[a]anthracene (BaA), benzo[a]pyrene (BaP), and 3-methylcholanthrene (3-MC)-and NSCLC. We identified a total of 30 gene targets associated with air pollutants in NSCLC. These findings highlight significant molecular alterations. Pathway enrichment analysis was then performed to identify crucial pathways implicated in tumorigenesis. Particular emphasis was placed on the cell cycle and p53 signaling pathways. RESULTS: Using machine learning, seven core genes (CKS1B, GAPDH, TYMS, AURKA, CCNE1, PARP1, and MGLL) were identified as promising diagnostic markers, achieving an area under the curve (AUC) value exceeding 0.95 during validation. Additionally, molecular docking revealed strong binding interactions between these core genes and selected air pollutants, with molecular dynamics simulations confirming the stability of these interactions. CONCLUSIONS: Our findings suggest a significant association between air pollutants and the development of NSCLC and propose potential biomarkers for enhanced diagnostic accuracy, alongside potential therapeutic targets. Future research should prioritize the clinical validation of these findings and the investigation of targeted therapies that consider environmental risk factors, thereby enhancing NSCLC management strategies and patient outcomes.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。